Martin Dow Marker

Martin Dow Marker is a leading pharmaceutical company in Pakistan, established following the acquisition of Merck KGaA's Pakistani operations by the Martin Dow Group in 2016. The company operates state-of-the-art manufacturing facilities in Quetta and Karachi, producing a wide range of high-quality branded generic medicines. Its portfolio spans multiple therapeutic areas, including cardiology, diabetes, oncology, and gastroenterology, maintaining the legacy of German quality standards. Martin Dow Marker is recognized for its robust distribution network and commitment to providing affordable healthcare solutions across the region. The company continues to collaborate with international partners to bring innovative treatments to the local market.